The effect on the renal functions and blood pressure of DPP-4 Inhibitor for the type 2 diabetic patients .

Not Applicable

• Conditions: Type 2 diabetes

• Registration Number: JPRN-UMIN000005337
• Lead Sponsor: Kanazawa Medical University Diadetes & Endocrinology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-03-29
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients with type 1 diabetes 2)History of severe ketosis, diabetic coma or precoma within 6 months 3)Patients with severe infections, before or after operation, or with serious trauma 4)Ptientswho are pregnant, breast-feeding and/or intention to become pregnant 5)Patients with the severe renal impairment 6)Patients receiving Alfa-glycosidase inhibitor, Glinide or Insulin 7)Patients receiving DPP-4 inhibitor other than Sitagliptin 8)Patients having allergies against DPP-4 inhibitor or alfa-Glycosidase inhibitor 9)Patients determined to be inappropriate for the study by physician based on the scientific grounds.

Study & Design

• Study Type: Interventional
• Study Design: Not specified